2. Iron Deficiency Anemia(IDA)
Anemia of Chronic Disease(ACD)
Megaloblastic Anemia
Hemolytic Anemia
Other Types
Aplastic Anemia(AA)
Anemia of CRF
3. Introduction
Epidemiology
Iron Metabolism
Causes
Clinical Features
Diagnosis
Differential Diagnoses
Treatment
4. The development & the rapidity of IDA is
dependent upon the body’s iron store.
Iron store in turn depends on
◦ Age
◦ Sex
◦ Rate of growth
◦ Balance b/n loss & absorption
Generally lower Iron values for women
because of menstrual loss, pregnancy,
lactation
5. IDA is supposed to be one of the commonest
forms in our country
1 - 2% even in the Western countries
Iron deficiency without anemia 11% in women (men 4%)
The WHO data on anemia 1997
2 billion people affected
Children & pregnant women most affected
Prevalence
Young children 48%
Pregnant women51%
Non-pregnant women 35%
Adult men 18%
6. On IDA
◦ Commonest among the nutritional anemias
◦ More prevalent in developing countries
36% vs 8%
Local data show similar pictures
◦ North Western Ethiopia
General population 40.5%
Children 47.2%
◦ Jimma
57% has been reported in pregnant women
7. Regulation of iron balance
◦ Interaction of various proteins
◦ Interplay b/n iron absorption & loss
8. Transferrin (Tf) & its receptors (TfR)
Ferritin
Iron responsive element-binding protein(
IRE-BP), IRP/IRF
HFE
Divalent Metal Transporter( DMT1)
Stimulator of iron transport(SFT)
Ferroportin & Hephaestin
Hepcidin
9. Transports Fe3+ through plasma
Synthesized in the liver
Increased production in deficiency states
Measured as Tf or TIBC
1/3rd saturated normally
Fe/Tf = 33%
10. States with decreased Tf saturation or
increased TIBC
IDA
ACD ( occasionally)
Ferroportin mutation
States with increased Tf saturation or
decreased TIBC
Aplastic anemia
Sideroblastic anemia
Ineffective erythropoiesis
hemochromatosis
11. Huge molecule for cellular storage of Fe
◦ 4500 atoms of iron
Acute phase reactant
Accessible for metabolic needs
Excess is changed to Hemosiderin
◦ Hemosiderin is not easy accessible for metabolism
Measured as apoferritin in the plasma
Plasma level reflects body iron store
◦ 1ng of ferritin= 10mg of total iron store
12. Normal body content = 3-4gm
HGB = 2.5gm
Other Fe containing proteins= 400mg
Tf bound in the plasma= 3-7mg
The rest as ferritin/hemosiderin= body Fe
store
◦ Adult men = 1gm
◦ Adult women = much less than men
Daily iron loss = 1mg
13. Diet contains heme & non-heme Fe
◦ 30% vs 10% absorbed
Released in the acidic environment and is
sent with mucin to the doudenum for
absorption
Enhancers vs Inhibitors
Ferric vs ferrous
14.
15.
16.
17. Blood loss( major cause)
◦ Obvious or occult
◦ GI loss the main, including Hook worm
Decreased absorption( uncommon)
◦ Part of generalized malabsorption like Celiac &
Tropical Sprue
19. IDA has 3stage
Stage 1
◦ Depleted iron store without anemia
◦ High risk of anemia with slightest bleeding
◦ Iron from daily RBC turn over
20. Stage 2
◦ Normocytic
◦ Normal reticulocyte count
◦ Common in developed countries
21. Stage 3
◦ Typical character
◦ In the face severe Fe deficiency
◦ Microcytic hypochromic
◦ Imbalance b/n heme & globulin synthesis
High EPO
LOW RETIC COUNT
22.
23. Features of anemia ( as discussed)
Typical of IDA
◦ KOILONYCHIA( SPOON NAILS)
◦ BLUE SCLERA
◦ PICA & PAGOPHAGIA
◦ BEETURIA
◦ PATERSON-KELLY/PLUMMER-VINSON SYNDROME
Dysphagia
Oesophageal web
Atrophic glossitis
24. Low HGB, HCT, RBC counts
Microcytic-hypochromic
◦ Low MCV, MCH &MCHC
◦ Increased central pallor
High Platelet count( Reactive thrombocytosis)
Normal WBC Count & Morphology
25. Low serum iron & ferritin
High Tf level
◦ Low saturation ( 2.5%)
◦ High TIBC
Absent iron stores
Brisk response to therapeutic trail
26.
27. The dx of IDA has 2 components
◦ Confirmation of iron deficiency
◦ Identify the cause
28. CBC &ESR
RBC INDICES
PERIPHERAL SMEAR
IRON STUDIES
◦ Serum iron
◦ Serum ferritin
◦ Serum Tf, TIBC
BM STUDY
THERAPEUTIC TRAIL & OTHERS
29. History is vital
◦ Gynecologic
◦ History of surgery
◦ Dietary habit
Stool exam
◦ Occult blood
◦ Ova of parasites
Endoscopy
colonoscopy
30. When anemia is mild with normal indices
(Stage 2 IDA)
◦ ACD
◦ Anemia due to CRF
◦ Anemia due to endocrine disorders
Classic(microcytic- hypochromic)
◦ Thalassemia
◦ Sideroblastic anemia
◦ ACD
◦ Lead poisoning
31. Two aspects
◦ Treatment of the underlying cause
◦ Administration of iron
32. General principles of iron treatment
Iron is absorbed in the duodenum & pro.jejunem
Shouldn’t be given with food
Best absorbed in a mildly acidic media
Give ascorbic acid
2hrs before or 4hrs after antacids
Cost and effectiveness
UGI discomfort is directly related to the amount of iron
Try the elixir
33. Oral preparation
◦ Ferrous sulfate 65mg of elemental iron
◦ Ferrous fumarate 106mg of elemental iron
◦ Ferrous gluconate 28-36mg of elemental iron
◦ Ferrous sulfate elixir 44mg/5ml
Side effect
◦ GI upset
34. 150-200mg of elemental iron
Response to treatment
◦ Reticulocytosis in 7days
◦ Rise in HGB 2g% over 3weeks
◦ Reasons for failure
Duration of treatment
◦ Continue after normalization of HGB to replenish
the iron stores
◦ 3-6months after normalization of HGB
35. Parenteral iron
◦ IV or IM
◦ Preparations
Iron dextran
Ferric gluconate
Iron sucrose
◦ Major side effects
Local & systemic
37. Also called anemia of chronic inflammation
ACD can be associated with conditions other
than inflammation, infection or malignancy:
Severe trauma
Heart disease
Diabetes
Acute or chronic immune reactivation
39. Primarily reflect a reduction in RBC
production but there may be a component
of RBC reduced survival
40. Three factors for hypoproliferative state
◦ Trapping of iron in macrophages
◦ Reduced sensitivity of BM to EPO
Normal marrow
Increase apoptosis of RBC precursors
◦ Relative reduction in EPO
42. Acute variant
◦ “Anemia of critical illness”
◦ Acute event related
Major surgery
MI
Sepsis
Major trauma
43. Anemia in ACD is of variable severity
◦ Many 10-11g% hgb
◦ Some(20%) will have HGB of 8g% or less
Low absolute reticulocyte count
High acute phase reactants & cytokines
Low serum iron & Tf level(TIBC)
44. 1/4th of patients are iron deficient
Serum ferritin normal or elevated
Bone marrow
◦ Macrophages increased or normal iron content
◦ Erythroid precursers – decreased or absent
45. ACD is usually NC & hypoproliferative
◦ CRF
◦ Severe endocrine disorders
46. Some patients with severe anemia &
microcytic hypochromic picture
◦ IDA
◦ THALASSEMIA
◦ SIDEROBLASTIC ANEMIA
47. Usually mild & may not interfere with quality
of life
Correction of underlying problem
Erythropoietin
◦ After measuring the level
◦ ?Survival
◦ Darbepoetin
Supplemental iron
◦ To maintain 20% or above saturation of Tf
49. Megaloblasts are nucleated RBC precursors
in the BM which maybe seen in rarely in
severe deficiency states
Macrocytic anemia is more appropriate
Anemia caused by vitamin B12(cobalamin)
deficiency and folate deficiency is similar
50. Vitamin B12 deficiency
◦ Take longer time to develop
◦ Neurological manifestations may come early
Folate deficiency
◦ Can develop in relatively short duration
Pregnancy
Acute & severe infection
Severe hemolysis
55. Masked by iron deficiency/ thalassemia
Neurologic manifestation
◦ Cyanobalamin
◦ Without anemia
Only hypersegemented neutrophils
56.
57. Evaluation has two stages
◦ Deficiency state
◦ Cause
History very important
CBC
Peripheral smear
Serum Cbl level
RBC folate level
58. Specific metabolites
◦ Elevated methylmalonic acid(MMA)
ONLY IN CBL def
◦ Elevated homocysteine
Both folate & Cbl deficiency
BM
Other tests
◦ Schilling test( 3 stages)
◦ Antibodies
Intrinsic factor
Parietal cell
Empiric treatment in the case of folate
deficiency
59.
60. Folate deficiency
◦ 1-5mg/day oral
◦ For 1-4months
◦ Complete hematologic recovery
Reduction in LDH in 2days
Reticulocytosis in 3-4days(peak in 1wk)
Rise in HBG & reduction in MCV in 8wks
Delay in cases of iron deficiency
61. Cobalamine deficiency
◦ IM CBL
1000microgram(1mg) daily for 1wk
1mg/wk for 1month
1mg/month then after
Cause not known or PA- give for life monthly
63. HA
◦ Vast group
◦ Important cause of anemia
◦ Shorted RBC survival
◦ Splenomegaly(hypersplenism)
Hemolysis
◦ Shorted RBC survival less than 100days
◦ Normal RBC survival- 120days
◦ Not necessarily HA
64. Random hemolysis
◦ Another way of RBC destruction besides the
death of aging (senescent) RBC
◦ Age independent
◦ Very low rate
Less than 0.05-0.5%
Increased in the case of splenomegaly & HA
◦ Well compensated normally by
Increased EPO production
Reticulocytosis
67. Absolute reticulocyte count
◦ Reticulocyte percent may not give all the
information about the BM response
◦ Normal value
25,000-75,000/microL
◦ Can be counted
◦ Corrected
Corrected ARC= ARC/retic maturation time
More informative
Reticulocyte production index(RPI)
◦ Two corrections
Survival shift
Degree of anemia
◦ Formula
RPI= retic% x (HCT/45) x ½
Normal 1
68. Different ways of classification of causes of
HA
◦ Intracorpuscular/ Extracorpuscular
◦ Inherited/ Acquired
◦ Intravascular/ extravascular
◦ Immune-mediated/ non-immune mediated
Immune mediated
Warm/ cold Antibody
69.
70. Starts with an accurate hx & P/E
Classic case
◦ New onset of pallor or anemia
◦ Jaundice ( high indirect bilirubin)
◦ Gallstones
◦ Splenomegaly
◦ Presence of circulating spherocytic RC
◦ Increased LDH
◦ Decreased serum haptoglobin
◦ + Coomb’s test
◦ High retic % or ARC